EUR/USD 1.19702
0.138%
Gold 5509.75
1.725%
Oil 64.236
1.429%
USD/JPY 153.286
-0.078%
GBP/USD 1.38194
0.088%
GBP/JPY 211.838
0.026%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
Market news: Tesla is accelerating its transformation from the electric vehicle sector to the robotics sector.Sunny Optical Technology (02382.HK) announced on the Hong Kong Stock Exchange that the Group expects its net profit attributable to shareholders in 2025 to be approximately RMB4.589 billion to RMB4.723 billion, representing a year-on-year increase of 70.0% to 75.0%. This is mainly attributed to: the promotion of high-end specifications for smartphone cameras, the improvement of the Groups product mix, the increase in the average selling price and gross profit margin of mobile phone lenses and mobile phone camera modules; and investment income of approximately RMB919 million from the transfer of equity in subsidiaries.Sunny Optical Technology (02382.HK) repurchased 15.84 million ordinary shares between January 8 and 28, and expects the companys profit attributable to shareholders to increase by approximately 70-75% year-on-year in 2025.On January 29th, Hengrui Medicine announced that its subsidiary, Shandong Shengdi Pharmaceutical Co., Ltd., recently received a "Drug Clinical Trial Approval Notice" from the National Medical Products Administration (NMPA) for HRS-7535 tablets, and will soon commence clinical trials. According to the "Drug Administration Law of the Peoples Republic of China" and relevant regulations, after review, the HRS-7535 tablets application, accepted on November 5, 2025, meets the relevant requirements for drug registration, and approval is granted for Phase III clinical trials. The intended indication is the treatment of chronic kidney disease.Sources say Alibaba’s new chip has attracted more than 400 customers.

NZD/USD falls rapidly from 0.6260 when the RBNZ announces a decline in inflation projections to 3.07 percent

Daniel Rogers

Aug 08, 2022 12:00

 截屏2022-08-08 上午11.52.29.png

 

The NZD/USD pair has encountered selling pressure while attempting to surpass the immediate resistance level of 0.6260. The asset has seen bids after the Reserve Bank of New Zealand (RBNZ) announced inflation estimates at 3.07 percent, down from 3.29 percent previously. It could be an indication of waning price pressure, but additional evidence is still needed to support the argument.

 

Price pressures in the New Zealand economy are increasing and have not yet shown signs of weariness. A June report indicates that an inflation rate of 7.3% is adequate to generate headwinds for families. The RBNZ is consistently escalating its policy tightening measures to combat the same. RBNZ Governor Adrian Orr has already increased the Official Cash Rate by 2.50 percentage points.

 

On the front of the US dollar, the US dollar index (DXY) has returned all intraday gains and is currently trading near the day's open at 106.60. While attempting to break over the crucial resistance level of 106.80, the DXY has encountered selling pressure. This week, investors' attention is centered on Wednesday's release of the US Consumer Price Index (CPI).

 

The annual inflation rate is projected to continue at 8.7 percent, down from 9.1 percent in the previous report. Oil prices have been on a downward trend in July, which may be the determining factor for a significant decline in the price increase index. While the US CPI excluding volatile food and oil prices may increase from 5.9 percent to 6.1 percent, the previous reading was 5.9 percent.

Suggestion